HR 5160 119th Congress

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Latest Action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Congress.gov

Sponsors

Rep. Smith, Christopher H. [R-NJ-4]

Rep. Smith, Christopher H. [R-NJ-4]

R — NJ

Summary

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Actions

2026-07-21T00:00:00

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

2026-07-20T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2026-07-20T00:00:00

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)

2026-07-20T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)

2026-07-20T00:00:00

DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.

2026-07-20T00:00:00

Considered under suspension of the rules. (consideration: CR H4642-4643)

2026-07-20T00:00:00

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

2026-07-02T00:00:00

Placed on the Union Calendar, Calendar No. 629.

2026-07-02T00:00:00

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

2026-07-02T00:00:00

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.

2026-05-21T00:00:00

Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

2026-05-21T00:00:00

Committee Consideration and Mark-up Session Held

2026-05-13T00:00:00

Forwarded by Subcommittee to Full Committee by Voice Vote.

2026-05-13T00:00:00

Subcommittee Consideration and Mark-up Session Held

2025-09-04T00:00:00

Referred to the Subcommittee on Health.

2025-09-04T00:00:00

Referred to the House Committee on Energy and Commerce.

2025-09-04T00:00:00

Introduced in House

2025-09-04T00:00:00

Introduced in House

Policy Areas

Health

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play